Literature DB >> 24778015

Reproducibility of histogram and texture parameters derived from intravoxel incoherent motion diffusion-weighted MRI of FN13762 rat breast Carcinomas.

Yong Sub Song1, Chang Min Park, Sang Min Lee, Sang Joon Park, Hye Rim Cho, Seung Hong Choi, Jeong Min Lee, Berthold Kiefer, Jin Mo Goo.   

Abstract

AIM: To determine the reproducibility of histogram and texture parameters derived from intravoxel incoherent motion (IVIM) diffusion-weighted magnetic resonance imaging (MRI) of FN13762 rat breast carcinomas.
MATERIALS AND METHODS: IVIM diffusion-weighted MRI was performed twice, nine days after tumor implantation in 11 rats. At each session, histogram and texture parameters of entire tumors were extracted from apparent diffusion coefficient (ADC), true-diffusion coefficient (Dt), pseudo-diffusion coefficient (Dp), and perfusion fraction (Pf) maps. Intraobserver and interscan measurement reproducibilities were evaluated using intraclass correlation coefficients (ICC).
RESULTS: Mean, entropy, 5th, 10th, 25th percentiles from ADC and Dt maps revealed good intra-observer and interscan agreements [lower limits of 95% confidence interval (CI) for ICC≥0.75]. However, all parameters from Dp and Pf maps gave relatively poor intra-observer and interscan agreements (lower limits of 95% CI for ICC<0.75).
CONCLUSION: Histogram and texture parameters derived from ADC and Dt maps were more reproducible than those from Dp and Pf maps.

Entities:  

Keywords:  FN13762 rat breast carcinoma; Reproducibility; diffusion-weighted MRI; histogram; intravoxel incoherent motion; texture

Mesh:

Year:  2014        PMID: 24778015

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  Texture analysis of medical images for radiotherapy applications.

Authors:  Elisa Scalco; Giovanna Rizzo
Journal:  Br J Radiol       Date:  2016-11-25       Impact factor: 3.039

2.  Correlation between conductivity and prognostic factors in invasive breast cancer using magnetic resonance electric properties tomography (MREPT).

Authors:  Soo-Yeon Kim; Jaewook Shin; Dong-Hyun Kim; Min Jung Kim; Eun-Kyung Kim; Hee Jung Moon; Jung Hyun Yoon
Journal:  Eur Radiol       Date:  2015-10-23       Impact factor: 5.315

3.  Evaluation of breast cancer using intravoxel incoherent motion (IVIM) histogram analysis: comparison with malignant status, histological subtype, and molecular prognostic factors.

Authors:  Gene Young Cho; Linda Moy; Sungheon G Kim; Steven H Baete; Melanie Moccaldi; James S Babb; Daniel K Sodickson; Eric E Sigmund
Journal:  Eur Radiol       Date:  2015-11-28       Impact factor: 5.315

4.  Apparent diffusion coefficient is highly reproducible on preclinical imaging systems: Evidence from a seven-center multivendor study.

Authors:  Sabrina Doblas; Gilberto S Almeida; François-Xavier Blé; Philippe Garteiser; Benjamin A Hoff; Dominick J O McIntyre; Lydia Wachsmuth; Thomas L Chenevert; Cornelius Faber; John R Griffiths; Andreas H Jacobs; David M Morris; James P B O'Connor; Simon P Robinson; Bernard E Van Beers; John C Waterton
Journal:  J Magn Reson Imaging       Date:  2015-05-26       Impact factor: 4.813

5.  Feasibility of IVIM parameters from diffusion-weighted imaging at 11.7T MRI for detecting ischemic changes in common carotid artery occlusion rats.

Authors:  Shunrou Fujiwara; Yuki Mori; Daniela Martinez de la Mora; Yosuke Akamatsu; Kenji Yoshida; Yuji Shibata; Tomoyuki Masuda; Kuniaki Ogasawara; Yoshichika Yoshioka
Journal:  Sci Rep       Date:  2020-05-21       Impact factor: 4.379

6.  Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast.

Authors:  Xiaoguang Li; Nianping Jiang; Chunlai Zhang; Xiangguo Luo; Peng Zhong; Jingqin Fang
Journal:  Cancer Imaging       Date:  2021-03-12       Impact factor: 3.909

7.  MR imaging biomarkers evaluating vascular normalization window after anti-vessel treatment.

Authors:  Jun Yang; Chengde Liao; Yifan Liu; Guangjun Yang; Tengfei Ke; Yingying Ding; Qinqing Li
Journal:  Oncotarget       Date:  2017-11-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.